Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
51 participants
INTERVENTIONAL
2021-02-02
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of High Power Laser Versus Low Level Laser in Ultrasonographic and Functional Outcomes in Patients With Knee Osteoarthritis
NCT06419569
Effect of High Intensity Laser in Treatment of Myofascial Trigger Points in Symptomatic Knee Osteoarthritis
NCT05148416
Different Levels of Blood Flow Restriction Versus Moderate Intensity Exercises in Patients with Knee Osteoarthritis
NCT06637124
Effect of Hip Abductors Versus Knee Extensor Strengthening in Knee Osteoarthritis
NCT04503304
HILT Dose Optimization for Knee Osteoarthritis Pain
NCT06916676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although little is known about the efficacy or mechanism of action of what has been termed ''high-intensity laser therapy'' using Nd: YAG lasers it has become commercially available in veterinary practice and is being marketed for the treatment of musculoskeletal disease. clinical research specific to Nd: YAG high-intensity laser therapy is required, as it is being used with little supporting evidence.
As there was no evidence about the best protocol for the treatment of knee OA as each study was using different doses, different sites of application, different number of phases, frequency of sessions, and the interval between sessions that make it difficult to have the best results. Specifically, the dosage range in literature was ranged from 1250 to 3000 J as total energy transmitted during one treatment session. The current study is an attempt to answer the question of which dosage of the energy of high-intensity LASER is more effective on pain and functional activities in patients with chronic knee OA at the third degree of osteoarthritis as determined by (Kellgren/Lawrence grading system) as it was recommended that LASER is an ideal treatment for subjects in the later stages of OA .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1500 J + exercises
consist of 17 patients, they will receive the application of HILT with intensity 1500 J plus exercises.
High Intensity Laser Therapy
different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
3000 J + exercises
consist of 17 patients, they will receive the application of HILT with intensity 3000 J plus exercises.
High Intensity Laser Therapy
different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
exercises + sham LASER
consist of 17 patients, they will apply exercises plus sham LASER.
High Intensity Laser Therapy
different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Intensity Laser Therapy
different doses of energies of high-intensity LASER on pain and functional activity in patients with chronic knee OA.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged between 50- 70 years
3. Persistent pain ≥4 on the visual analog scale (VAS) for more than 3 months in one or both knees.
4. Body mass index (BMI) ≤30 kg/m2.
5. Self-reported disability due to knee pain with a score of at least 25 on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
6. All subjects who will participate in this study will read, sign and date an informed consent form which required by ethical committee of faculty of physical therapy, Cairo university
Exclusion Criteria
* History of joint replacement.
* Symptoms or signs suggestive of another cause of knee pain.
* Rheumatoid arthritis.
* Steroid injection or knee surgery (previous six months).
* acute inflammation around knee joint.
* Underlying disease such as malignancy.
* Infection or systemic disease of musculoskeletal system
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mona Mohamed Ibrahim
Assistant Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HILT and Knee OA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.